This suggests that DPY30 plays an important role in promoting the expression of oncogenes, which is consistent with the conclusion found in this study that it promotes the transcription of PCNA and Ki67, thus promoting CRC progression. This evidence concerns the gene MKI67 and colorectal carcinoma.